A 5′ extended IFN-stimulating response element is crucial for IFN-γ-induced tripartite motif 22 expression via interaction with IFN regulatory factor-1

Journal of Immunology

Volumn 185, Issue 4, 2010, Pages 2314-2323

  Gao, Bo ^a   Wang, Yaxin ^a   Xu, Wei ^a   Duan, Zhijian ^a   Xiong, Sidong ^a,b  

^a FUDAN UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5' EXTENDED INTERFERON STIMULATING RESPONSE ELEMENT; GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 1; LUCIFERASE; SMALL INTERFERING RNA; STAT1 PROTEIN; TRANSCRIPTION FACTOR; TRIPARTITE MOTIF PROTEIN 22; TRIPARTITE MOTIF PROTEIN 5; UNCLASSIFIED DRUG; CYCLOHEXIMIDE; HYBRID PROTEIN; PROTEIN SYNTHESIS INHIBITOR; REPRESSOR PROTEIN; TRIM22 PROTEIN, HUMAN;

ARTICLE; CELL STRAIN HEPG2; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA PROTEIN COMPLEX; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; GENE INDUCTION; GENE INTERACTION; GENE SEQUENCE; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INTERFERON INDUCTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; TRANSIENT EXPRESSION; WESTERN BLOTTING; BINDING SITE; DNA FLANKING REGION; DNA RESPONSIVE ELEMENT; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; MUTATION; NUCLEOTIDE SEQUENCE; RNA INTERFERENCE;

5' FLANKING REGION; BASE SEQUENCE; BINDING SITES; BLOTTING, WESTERN; CYCLOHEXIMIDE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; INTERFERON REGULATORY FACTOR-1; INTERFERON-GAMMA; LUCIFERASES; MUTATION; PROTEIN BINDING; PROTEIN SYNTHESIS INHIBITORS; RECOMBINANT FUSION PROTEINS; REPRESSOR PROTEINS; RESPONSE ELEMENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSFECTION;

EID: 77956896934     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001053     Document Type: Article

References (49)

1. Reymond, A., G. Meroni, A. Fantozzi, G. Merla, S. Cairo, L. Luzi, D. Riganelli, E. Zanaria, S. Messali, S. Cainarca, et al. 2001. The tripartite motif family identifies cell compartments. EMBO J. 20: 2140-2151. (Pubitemid 32410584)
2. Meroni, G., and G. Diez-Roux. 2005. TRIM/RBCC, a novel class of 'single protein RING finger' E3 ubiquitin ligases. Bioessays 27: 1147-1157.
3. Yamauchi, K., K. Wada, K. Tanji, M. Tanaka, and T. Kamitani. 2008. Ubiquitination of E3 ubiquitin ligase TRIM5 alpha and its potential role. FEBS J. 275: 1540-1555. (Pubitemid 351388800)
4. Duan, Z., B. Gao, W. Xu, and S. Xiong. 2008. Identification of TRIM22 as a RING finger E3 ubiquitin ligase. Biochem. Biophys. Res. Commun. 374: 502-506.
5. Gack, M. U., Y. C. Shin, C. H. Joo, T. Urano, C. Liang, L. Sun, O. Takeuchi, S. Akira, Z. Chen, S. Inoue, and J. U. Jung. 2007. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446: 916-920.
6. Stremlau, M., C. M. Owens, M. J. Perron, M. Kiessling, P. Autissier, and J. Sodroski. 2004. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427: 848-853.
7. Neagu, M. R., P. Ziegler, T. Pertel, C. Strambio-De-Castillia, C. Grütter, G. Martinetti, L. Mazzucchelli, M. Grütter, M. G. Manz, and J. Luban. 2009. Potent inhibition of HIV-1 by TRIM5-cyclophilin fusion proteins engineered from human components. J. Clin. Invest. 119: 3035-3047.
8. Gack, M. U., A. Kirchhofer, Y. C. Shin, K. S. Inn, C. Liang, S. Cui, S. Myong, T. Ha, K. P. Hopfner, and J. U. Jung. 2008. Roles of RIG-I N-terminal tandem CARD and splice variant in TRIM25-mediated antiviral signal transduction. Proc. Natl. Acad. Sci. USA 105: 16743-16748.
9. Wolf, D., and S. P. Goff. 2007. TRIM28 mediates primer binding site-targeted silencing of murine leukemia virus in embryonic cells. Cell 131: 46-57.
10. Wolf, D., K. Hug, and S. P. Goff. 2008. TRIM28 mediates primer binding site-targeted silencing of Lys1,2 tRNA-utilizing retroviruses in embryonic cells. Proc. Natl. Acad. Sci. USA 105: 12521-12526.
11. Nisole, S., J. P. Stoye, and A. Saïb. 2005. TRIM family proteins: retroviral restriction and antiviral defence. Nat. Rev. Microbiol. 3: 799-808.
12. Ozato, K., D. M. Shin, T. H. Chang, and H. C. Morse, III. 2008. TRIM family proteins and their emerging roles in innate immunity. Nat. Rev. Immunol. 8: 849-860.
13. Gao, B., Z. Duan, W. Xu, and S. Xiong. 2009. Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain. Hepatology 50: 424-433.
14. Eldin, P., L. Papon, A. Oteiza, E. Brocchi, T. G. Lawson, and N. Mechti. 2009. TRIM22 E3 ubiquitin ligase activity is required to mediate antiviral activity against encephalomyocarditis virus. J. Gen. Virol. 90: 536-545.
15. Barr, S. D., J. R. Smiley, and F. D. Bushman. 2008. The interferon response inhibits HIV particle production by induction of TRIM22. PLoS Pathog. 4: e1000007.
16. Bouazzaoui, A., M. Kreutz, V. Eisert, N. Dinauer, A. Heinzelmann, S. Hallenberger, J. Strayle, R. Walker, H. Rübsamen-Waigmann, R. Andreesen, and H. von Briesen. 2006. Stimulated trans-acting factor of 50 kDa (Staf50) inhibits HIV-1 replication in human monocyte-derived macrophages. Virology 356: 79-94.
17. Tissot, C., and N. Mechti. 1995. Molecular cloning of a new interferon-induced factor that represses human immunodeficiency virus type 1 long terminal repeat expression. J. Biol. Chem. 270: 14891-14898.
18. Platanias, L. C. 2005. Mechanisms of type-I- and type-II-interferon- mediated signalling. Nat. Rev. Immunol. 5: 375-386.
19. Stark, G. R. 2007. How cells respond to interferons revisited: from early history to current complexity. Cytokine Growth Factor Rev. 18: 419-423.
20. Uddin, S., and L. C. Platanias. 2004. Mechanisms of type-I interferon signal transduction. J. Biochem. Mol. Biol. 37: 635-641.
21. van Boxel-Dezaire, A. H., and G. R. Stark. 2007. Cell type-specific signaling in response to interferon-gamma. Curr. Top. Microbiol. Immunol. 316: 119-154.
22. Gough, D. J., D. E. Levy, R. W. Johnstone, and C. J. Clarke. 2008. IFNgamma signaling-does it mean JAK-STAT? Cytokine Growth Factor Rev. 19: 383-394.
23. Liu, X., L. Ye, Y. Bai, H. Mojidi, N. E. Simister, and X. Zhu. 2008. Activation of the JAK/STAT-1 signaling pathway by IFN-gamma can down-regulate functional expression of the MHC class I-related neonatal Fc receptor for IgG. J. Immunol. 181: 449-463.
24. Sivaramakrishnan, G., Y. Sun, S. K. Tan, and V. C. Lin. 2009. Dynamic localization of tripartite motif-containing 22 in nuclear and nucleolar bodies. Exp. Cell Res. 315: 1521-1532.
25. Obad, S., H. Brunnström, J. Vallon-Christersson, A. Borg, K. Drott, and U. Gullberg. 2004. Staf50 is a novel p53 target gene conferring reduced clonogenic growth of leukemic U-937 cells. Oncogene 23: 4050-4059.
26. McKay, I. A., L. Kirby, E. V. Volyanik, V. Kumar, P. W. Wong, and S. A. Bustin. 1998. An enzyme-linked immunosorbent assay for the detection of agents which interfere with the DNA binding activities of transcription factors - exemplified by NF-IL6. Anal. Biochem. 265: 28-34.
27. Reid, L. E., A. H. Brasnett, C. S. Gilbert, A. C. Porter, D. R. Gewert, G. R. Stark, and I. M. Kerr. 1989. A single DNA response element can confer inducibility by both alpha- and gamma-interferons. Proc. Natl. Acad. Sci. USA 86: 840-844.
28. Qureshi, S. A., M. Salditt-Georgieff, and J. E. Darnell, Jr. 1995. Tyrosine-phosphorylated Stat1 and Stat2 plus a 48-kDa protein all contact DNA in forming interferon-stimulated-gene factor 3. Proc. Natl. Acad. Sci. USA 92: 3829-3833.
29. Kalvakolanu, D. V. 2003. Alternate interferon signaling pathways. Pharmacol. Ther. 100: 1-29.
30. Fu, X. Y., C. Schindler, T. Improta, R. Aebersold, and J. E. Darnell, Jr. 1992. The proteins of ISGF-3, the interferon alpha-induced transcriptional activator, define a gene family involved in signal transduction. Proc. Natl. Acad. Sci. USA 89: 7840-7843.
31. van Boxel-Dezaire, A. H., M. R. Rani, and G. R. Stark. 2006. Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 25: 361-372.
32. Gongora, C., G. Degols, L. Espert, T. D. Hua, and N. Mechti. 2000. A unique ISRE, in the TATA-less human Isg20 promoter, confers IRF-1-mediated responsiveness to both interferon type I and type II. Nucleic Acids Res. 28: 2333-2341. (Pubitemid 30349038)
33. Lefebvre, S., S. Berrih-Aknin, F. Adrian, P. Moreau, S. Poea, L. Gourand, J. Dausset, E. D. Carosella, and P. Paul. 2001. A specific interferon (IFN)-stimulated response element of the distal HLA-G promoter binds IFN-regulatory factor 1 and mediates enhancement of this nonclassical class I gene by IFN-beta. J. Biol. Chem. 276: 6133-6139.
34. Ruiz-Ruiz, C., C. Ruiz de Almodóvar, A. Rodríguez, G. Ortiz-Ferrón, J. M. Redondo, and A. López-Rivas. 2004. The up-regulation of human caspase-8 by interferon-gamma in breast tumor cells requires the induction and action of the transcription factor interferon regulatory factor-1. J. Biol. Chem. 279: 19712-19720.
35. Ganem, D., and A. M. Prince. 2004. Hepatitis B virus infection - natural history and clinical consequences. N. Engl. J. Med. 350: 1118-1129.
36. Wieland, S. F., A. Eustaquio, C. Whitten-Bauer, B. Boyd, and F. V. Chisari. 2005. Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids. Proc. Natl. Acad. Sci. USA 102: 9913-9917.
37. Guidotti, L. G., A. Morris, H. Mendez, R. Koch, R. H. Silverman, B. R. G. Williams, and F. V. Chisari. 2002. Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice. J. Virol. 76: 2617-2621.
38. Wieland, S., R. Thimme, R. H. Purcell, and F. V. Chisari. 2004. Genomic analysis of the host response to hepatitis B virus infection. Proc. Natl. Acad. Sci. USA 101: 6669-6674.
39. Wieland, S. F., and F. V. Chisari. 2005. Stealth and cunning: hepatitis B and hepatitis C viruses. J. Virol. 79: 9369-9380.
40. Chen, C. J., T. T. Lin, and J. E. Shively. 1996. Role of interferon regulatory factor-1 in the induction of biliary glycoprotein (cell CAM-1) by interferon-gamma. J. Biol. Chem. 271: 28181-28188.
41. Masumi, A., S. Tamaoki, I. M. Wang, K. Ozato, and K. Komuro. 2002. IRF-8/ICSBP and IRF-1 cooperatively stimulate mouse IL-12 promoter activity in macrophages. FEBS Lett. 531: 348-353.
42. Gobin, S. J., P. Biesta, and P. J. Van den Elsen. 2003. Regulation of human beta 2-microglobulin transactivation in hematopoietic cells. Blood 101: 3058-3064.
43. Lorsbach, R. B., W. J. Murphy, C. J. Lowenstein, S. H. Snyder, and S.W. Russell. 1993. Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. Molecular basis for the synergy between interferon-gamma and lipopolysaccharide. J. Biol. Chem. 268: 1908-1913.
44. Kumatori, A., D. Yang, S. Suzuki, and M. Nakamura. 2002. Cooperation of STAT-1 and IRF-1 in interferon-gamma-induced transcription of the gp91(phox) gene. J. Biol. Chem. 277: 9103-9111.
45. Briken, V., H. Ruffner, U. Schultz, A. Schwarz, L. F. Reis, I. Strehlow, T. Decker, and P. Staeheli. 1995. Interferon regulatory factor 1 is required for mouse Gbp gene activation by gamma interferon. Mol. Cell. Biol. 15: 975-982.
46. Wong, L. H., H. Sim, M. Chatterjee-Kishore, I. Hatzinisiriou, R. J. Devenish, G. Stark, and S. J. Ralph. 2002. Isolation and characterization of a human STAT1 gene regulatory element. Inducibility by interferon (IFN) types I and II and role of IFN regulatory factor-1. J. Biol. Chem. 277: 19408-19417.
47. Rajsbaum, R., J. P. Stoye, and A. O'Garra. 2008. Type I interferon-dependent and -independent expression of tripartite motif proteins in immune cells. Eur. J. Immunol. 38: 619-630.
48. Sawyer, S. L., M. Emerman, and H. S. Malik. 2007. Discordant evolution of the adjacent antiretroviral genes TRIM22 and TRIM5 in mammals. PLoS Pathog. 3: e197.
49. Asaoka, K., K. Ikeda, T. Hishinuma, K. Horie-Inoue, S. Takeda, and S. Inoue. 2005. A retrovirus restriction factor TRIM5alpha is transcriptionally regulated by interferons. Biochem. Biophys. Res. Commun. 338: 1950-1956.